Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
technology development project in which UCC collaborates with two companies, Danalto and Qorvo. The UCC part of the project focuses on the development of agentic AI and digital twin concepts for Ultra-Wideband
-
an EPE and Societal Impact Manager to lead the public engagement and societal impact programme of its new Research Ireland Centre for Quantum Information Science and Technology, Rinn Quantum. This is a
-
implementation of pharmacogenomics and multiomics in clinical practice. The role will focus on conducting a comprehensive Health Technology Assessment (HTA), synthesising evidence on clinical effectiveness and
-
education, research, and innovation, which has been inspiring generations of thinkers for over 400 years. Thrive: Trinity College Dublin's Strategic Plan 2025 - 2030 The School of Engineering seeks to make
-
22 Jul 2026 Job Information Organisation/Company University College Dublin Research Field Engineering » Biomaterial engineering Researcher Profile Recognised Researcher (R2) Application Deadline 4
-
21 Months Fixed Term, Whole-time Post The researcher will be employed on a technology development project in which UCC collaborates with two companies, Danalto and Qorvo. The UCC part of the project
-
technology development project in which UCC collaborates with two companies, Danalto and Qorvo. The UCC part of the project focuses on the development of agentic AI and digital twin concepts for Ultra-Wideband
-
. Materials costs not significant) https://www.tudublin.ie/explore/faculties-and-schools/engineering-built… Where to apply Website https://forms.office.com/e/0hCcrv2Gkp Requirements Research FieldEngineering
-
emerging from University College Cork, Teagasc and APC Microbiome Ireland. NourishMind is developing novel microbiota-based product(s) for weight maintenance. The technology is supported by a growing body of
-
on conducting a comprehensive Health Technology Assessment (HTA), synthesising evidence on clinical effectiveness and safety, pharmacoeconomic and cost-effectiveness outcomes, budget impact, organisational and